Friday, May 13th, 2016

About Insulin 

Beta cells of the pancreas produce insulin, a hormone that regulates blood glucose levels, by stimulating cells to absorb glucose from the blood. In the cells, glucose is converted into energy, which is used by tissues and muscles to perform their physiological functions. This process is restricted in people with diabetes, resulting in the accumulation of glucose in the blood. This condition is known as hyperglycemia; it damages body tissues over a period, leading to life-threatening health complications such as diabetic retinopathy and diabetic nephropathy. In type 1 diabetes or gestational diabetes, the immune system attacks the pancreatic cells, resulting in little or no insulin production. In type 2 diabetes, the body does not produce sufficient insulin to regulate blood glucose levels. In both type 1 and type 2 diabetes, the individual requires daily doses of insulin along with other medications, depending on the condition. Different types of insulin products, such as human insulin and insulin analogs, are available for insulin replacement therapy. 

Technavio’s analysts forecast the insulin market in the US and Europe to grow at a CAGR of 6.17% during the period 2016-2020. 

Complete report details @                                

Covered in this report 
The report covers the present scenario and the growth prospects of the insulin market in the US and Europe for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the branded drugs during the forecast period. 

The market is divided into the following segments based on geography: 
• US 
• Europe 

Technavio's report, Insulin Market in the US and Europe 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Request a sample report @                


Key vendors 
• Sanofi 
• Novo Nordisk 
• Eli Lilly 
Other prominent vendors 
• Adocia 
• Biocon 
• Biodel 
• Biogenomics 
• Boehringer Ingelheim 
• Dance Biopharm 
• Diasome Pharmaceuticals 
• Exsulin 
• Generex 
• Lexicon Pharmaceuticals 
• Ligand Pharmaceuticals 
• MannKind 
• Macrogenics 
• Merck 
• Melior Pharmaceuticals 
• Metabolic Solutions Development Company 
• NGM Biopharmaceuticals 
• NuSirt Biopharma 
• Oramed Pharmceuticals 
• PhaseBio Pharmaceuticals 
• Pfizer 
• Thermalin Diabetes 
• Tolerion 
• VeroScience 
• vTv Therapeutics 
• Wockhardt 

Market driver 
• Advances in insulin delivery technology 
• For a full, detailed list, view our report 

Market challenge 
• Complexity of insulin production 
• For a full, detailed list, view our report 

Market trend 
• Increasing price of insulin drugs 
• For a full, detailed list, view our report 

Key questions answered in this report 
• What will the market size be in 2020 and what will the growth rate be? 
• What are the key market trends? 
• What is driving this market? 
• What are the challenges to market growth? 
• Who are the key vendors in this market space? 
• What are the market opportunities and threats faced by the key vendors? 
• What are the strengths and weaknesses of the key vendors? 

Make an enquiry before buying this Report @                               


Table of content

PART 01: Executive summary 
• Highlights 
PART 02: Scope of the report 
• Market overview 
• Assumptions: 
• Top-vendor offerings 
PART 03: Market research methodology 
• Research methodology 
• Economic indicators 
PART 04: Introduction 
• Key market highlights 
• Key buying criteria 
PART 05: Major branded drug profiles 
• Actrapid 
• Apidra 
• Humalog 
• Insuman 
• Lantus 
• Levemir 
• NovoMix 
• NovoRapid 
• Toujeo 
• Tresiba 
PART 06: Insulin: An overview 
• History of insulin 
• Epidemiology 
• Reimbursement scenario 
• Patent scenario for approved products 
PART 07: Pipeline portfolio 
• Xultophy (NN9068) 
• Faster-acting insulin aspart (NN1218) 
• SAR342434 
• LY2605541 
• MK-1293 
• Oral-Lyn 
PART 08: Oral insulin therapies 
• Upcoming vendors for oral insulin therapies 
• Oramed Pharmaceuticals 
• Generex Biotechnology 
PART 09: Market landscape 
• Global insulin market 
• Insulin market in US and Europe 
• Market size and forecast 
• Five forces analysis 
PART 10: Market segmentation by drug class 
• Fast-acting insulin 

• Intermediate-acting insulin 
• Long-acting insulin 
PART 11: Market segmentation by application 
• Type 1 diabetes 
• Type 2 diabetes 
PART 12: Market segmentation by insulin delivery technologies 
• Injectable insulin 
• Oral insulin 
• Inhaled insulin 
• Other emerging insulin delivery technologies 
• Insulin pumps 
PART 13: Geographical segmentation 
• Insulin market in US 
• Insulin market in Europe 
PART 14: Market drivers 
• Advances in insulin delivery technology 
• Unmet medical needs 
• Increase in prevalence of diabetes and obesity 
• Increase in awareness of diabetes 
PART 15: Impact of drivers 
PART 16: Market challenges 

• Complexity of insulin production 
• Poor storage condition and distribution policies 
• Stringent regulatory environment 
• Inconvenient ROA 
PART 17: Impact of drivers and challenges 
PART 18: Market trends 

• Increase in R&D for novel mechanisms 
• Increase in academia-industry collaborations for drug development 
• Increasing price of insulin drugs 
• Intense competition among present and upcoming vendors 
PART 19: Vendor landscape 
• Competitive scenario 
• Market share analysis 2015 
• Sanofi 
• Novo Nordisk 
• Eli Lilly 
• Other prominent vendors 
PART 20: Appendix 

Buy this report @


Contact US:


Partner Relations & Marketing Manager

[email protected]

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)          



File Library

Contact Profile


Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Our Market Research Reports and Consulting Services 

Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The Wise Guy Reports team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and corporate service for large organizations.

Hundreds of large and small organizations across virtually every industry sector worldwide are currently reaping rich dividends from the sharp insights provided by market research reports sourced through Wise Guy Reports. 

Gaining an insight into emerging trends, opportunities and potential threats is key to long-term sustenance in a competitive environment. The handpicked collection of market research reports on Wise Guy Reports is centred on this proven principle.

Norah Trent
P: +44 208 133 9349
M: +1 646 845 9349


Insulin market trend, Insulin market segmentation, Insulin market analysis, Insulin market parameters, Insulin industry forecast, Insulin market size, Insulin market share, Insulin market growth




More Formats

View QR Code